How A Research Proposal Moves Through NIH

{WantNoCacheVal} How A Research Proposal Moves Through NIH When a grant proposal arrives at NIH's, Bethesda. Md., headquarters it is routed directly to the agency's Division of Research Grants. There, one of a dozen or so "referral officers" identifies the scientific field to the most appropriate of the agency's 93 standing commit- tees review to the so-called "study sections." A study section consists of from 14 to 20 scientists representing a widerange of specialties: The Surgery, Anesthesi

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

When a grant proposal arrives at NIH's, Bethesda. Md., headquarters it is routed directly to the agency's Division of Research Grants. There, one of a dozen or so "referral officers" identifies the scientific field to the most appropriate of the agency's 93 standing commit- tees review to the so-called "study sections."

A study section consists of from 14 to 20 scientists representing a widerange of specialties: The Surgery, Anesthesiology, and Trauma Study Section, for example, might include biochemists, burn physiologists, toxicologists, and specialists in drug metabolism.

Each proposal gets an in-depth reading from at least two section members--referred to as the primary and secondary reviewers. When the study section meets the two reviewers discuss the proposal's scientific merit with their colleagues, and all of the reviewers in the section then vote to approve, disapprove, or defer decision on the proposal.

Also, all members assign to each proposal a priority score ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies